The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Biomarker analysis from a phase III trial (GOLD) of dovitinib (Dov) versus sorafenib (Sor) in patients with metastatic renal cell carcinoma after one prior VEGF pathway–targeted therapy and one prior mTOR inhibitor therapy.
Bernard J. Escudier
Consultant or Advisory Role - Bayer; GlaxoSmithKline; Novartis; Pfizer
Honoraria - Bayer; Genentech; GlaxoSmithKline; Novartis; Pfizer
Camillo Porta
Consultant or Advisory Role - Astellas Pharma; AVEO; Bayer Schering Pharma; Boehringer Ingelheim; GlaxoSmithKline; Novartis; Pfizer
Honoraria - Astellas Pharma; Bayer Schering Pharma; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bayer Schering Pharma; Novartis
Matthew Squires
Employment or Leadership Position - Novartis
Cezary Szczylik
Consultant or Advisory Role - Astellas Pharma; GlaxoSmithKline; Novartis; Pfizer
Honoraria - Astellas Pharma; GlaxoSmithKline; Novartis; Pfizer
Christian K. Kollmannsberger
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Pfizer
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Bohuslav Melichar
Consultant or Advisory Role - Astellas Pharma; Bayer; GlaxoSmithKline; Novartis; Roche
Honoraria - GlaxoSmithKline; Novartis; Roche
Sun Young Rha
No relevant relationships to disclose
Emilio Esteban
No relevant relationships to disclose
Georg A. Bjarnason
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Nicholas J. Vogelzang
Employment or Leadership Position - US Oncology
Consultant or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Celgene; Clinical Care Options; Dendreon; Eisai; Genentech; GlaxoSmithKline; Johnson & Johnson; Millennium; Novartis; Pfizer; Veridex; Viamet Pharmaceuticals
Research Funding - Algeta; GlaxoSmithKline; Johnson & Johnson; Millennium; Novartis; Pfizer; Tokai; Veridex; Wilex
Other Remuneration - Amgen; Astellas Pharma; Bayer; Clinical Care Options; Dendreon; Genentech; Johnson & Johnson; Lilly; Novartis; Pfizer; Quintiles; Sanofi ; Veridex; Wilex
Cora N. Sternberg
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Michael Shi
Employment or Leadership Position - Novartis
Mathab Marker
Employment or Leadership Position - Novartis
Robert John Motzer
Consultant or Advisory Role - Bayer
Research Funding - Novartis